Literature DB >> 35924018

Distribution and Drug Resistance of Pathogenic Bacteria and Prognosis in Patients with Septicemia Bloodstream Infection with Renal Insufficiency.

Deng Pan1, Pin Peng2, Yu Fang3, Jun Lu3, Minghao Fang3.   

Abstract

Objective: The aim of this study was to investigate the distribution and drug resistance of pathogenic bacteria and the prognosis of patients with sepsis bloodstream infection with renal insufficiency.
Methods: One hundred and twelve patients with septicemic bloodstream infection with renal insufficiency and 112 patients with septic bloodstream infection without renal insufficiency were selected as study group and control group, respectively. We compare the distribution of pathogenic bacteria, analyze the drug resistance of major bacteria, and compare the efficacy, the incidence of septic shock, duration of mechanical ventilation, hospitalization time, and duration of antimicrobial drug administration between the two groups.
Results: A total of 140 pathogenic strains were isolated from blood cultures in the study group, and 136 strains were isolated from blood cultures in the control group. The sepsis bloodstream infection was mainly caused by Gram-negative bacteria, accounting for 59.42% (164/276). Among the gram-negative bacteria, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii had higher resistance rates to levofloxacin, ceftazidime, piperacillin sodium tazobactam, and amikacin. Among the gram-positive bacteria, Streptococcus pneumoniae, Enterococcus, and Staphylococcus aureus had high resistance rates to clindamycin, cefazolin, penicillin G, gentamicin, azithromycin, and levofloxacin. The rate of extended spectrum β-lactamase (ESBLs)-producing enterobacteria and multi-drug resistant Pseudomonas aeruginosa (MDR-PA) infection was significantly higher in the study group than in the control group; there was no difference in multi-drug resistant Acinetobacter baumannii (MDR-AB), vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA) between the two groups. The duration of hospitalization and the duration of antimicrobial drug administration were longer in the study group than in the control group.
Conclusion: The pathogenic bacteria in patients with sepsis bloodstream infection with renal insufficiency are mainly Gram-negative bacteria, are more difficult to be cured, have a longer course of treatment, and need to use antibacterial drugs for a long time.
© 2022 Pan et al.

Entities:  

Keywords:  drug resistance; pathogenic bacteria; prognosis; sepsis bloodstream infection with renal insufficiency

Year:  2022        PMID: 35924018      PMCID: PMC9342692          DOI: 10.2147/IDR.S373665

Source DB:  PubMed          Journal:  Infect Drug Resist        ISSN: 1178-6973            Impact factor:   4.177


  22 in total

1.  The Declaration of Helsinki.

Authors:  Michael D E Goodyear; Karmela Krleza-Jeric; Trudo Lemmens
Journal:  BMJ       Date:  2007-09-29

2.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Christopher W Seymour; Vincent X Liu; Theodore J Iwashyna; Frank M Brunkhorst; Thomas D Rea; André Scherag; Gordon Rubenfeld; Jeremy M Kahn; Manu Shankar-Hari; Mervyn Singer; Clifford S Deutschman; Gabriel J Escobar; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

Review 3.  [Clarification of renal insufficiency in geriatric patients].

Authors:  Steffen Krautzig
Journal:  Z Gerontol Geriatr       Date:  2021-04-08       Impact factor: 1.281

4.  Risk factors and mortality associated with multi-drug-resistant Gram-negative bacterial infection in adult patients following abdominal surgery.

Authors:  T-L Lin; P-H Chang; I-L Chen; W-H Lai; Y-J Chen; W-F Li; I-K Lee; C-C Wang
Journal:  J Hosp Infect       Date:  2021-10-07       Impact factor: 3.926

5.  Fluoroquinolone versus Beta-Lactam Oral Step-Down Therapy for Uncomplicated Streptococcal Bloodstream Infections.

Authors:  Kellie Arensman; Maureen Shields; Maya Beganovic; Jessica L Miller; Erik LaChance; Morgan Anderson; Jennifer Dela-Pena
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

Review 6.  Update on bacterial nosocomial infections.

Authors:  W Bereket; K Hemalatha; B Getenet; T Wondwossen; A Solomon; A Zeynudin; S Kannan
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-08       Impact factor: 3.507

7.  Accelerated Aging and Clearance of Host Anti-inflammatory Enzymes by Discrete Pathogens Fuels Sepsis.

Authors:  Won Ho Yang; Douglas M Heithoff; Peter V Aziz; Benjamin Haslund-Gourley; Julia S Westman; Sonoko Narisawa; Anthony B Pinkerton; José Luis Millán; Victor Nizet; Michael J Mahan; Jamey D Marth
Journal:  Cell Host Microbe       Date:  2018-10-10       Impact factor: 21.023

8.  Universal microbial diagnostics using random DNA probes.

Authors:  Amirali Aghazadeh; Adam Y Lin; Mona A Sheikh; Allen L Chen; Lisa M Atkins; Coreen L Johnson; Joseph F Petrosino; Rebekah A Drezek; Richard G Baraniuk
Journal:  Sci Adv       Date:  2016-09-28       Impact factor: 14.136

9.  Sepsis-A Retrospective Cohort Study of Bloodstream Infections.

Authors:  Biagio Santella; Veronica Folliero; Gerarda Maria Pirofalo; Enrica Serretiello; Carla Zannella; Giuseppina Moccia; Emanuela Santoro; Giuseppina Sanna; Oriana Motta; Francesco De Caro; Pasquale Pagliano; Mario Capunzo; Massimiliano Galdiero; Giovanni Boccia; Gianluigi Franci
Journal:  Antibiotics (Basel)       Date:  2020-11-28

10.  Bacterial bloodstream infections in neonates in a developing country.

Authors:  Daynia E Ballot; Trusha Nana; Charlotte Sriruttan; Peter A Cooper
Journal:  ISRN Pediatr       Date:  2012-08-05
View more
  1 in total

1.  Microbial Nomenclature and Laboratory Standards: Two Key Aspects to Consider [Letter].

Authors:  Narinder Kaur; Nitin Kumar; Harit Kumar
Journal:  Infect Drug Resist       Date:  2022-08-26       Impact factor: 4.177

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.